Cite
Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?
MLA
Nicholls, Stephen J., et al. “Evaluating Obicetrapib as an Emerging Treatment for Patients with Dyslipidemia: A Game Changer?” Expert Opinion on Pharmacotherapy, vol. 25, no. 14, Oct. 2024, pp. 1879–85. EBSCOhost, https://doi.org/10.1080/14656566.2024.2409324.
APA
Nicholls, S. J., Tan, S., Butters, J., & Nelson, A. J. (2024). Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer? Expert Opinion on Pharmacotherapy, 25(14), 1879–1885. https://doi.org/10.1080/14656566.2024.2409324
Chicago
Nicholls, Stephen J, Sean Tan, Julie Butters, and Adam J Nelson. 2024. “Evaluating Obicetrapib as an Emerging Treatment for Patients with Dyslipidemia: A Game Changer?” Expert Opinion on Pharmacotherapy 25 (14): 1879–85. doi:10.1080/14656566.2024.2409324.